Sarizotan, a serotonin 5-HT1A receptor agonist and dopamine receptor ligand. 1. Neurochemical profile.
about
F15063, a compound with D2/D3 antagonist, 5-HT 1A agonist and D4 partial agonist properties. II. Activity in models of positive symptoms of schizophrenia.F15063, a compound with D2/D3 antagonist, 5-HT 1A agonist and D4 partial agonist properties. III. Activity in models of cognition and negative symptoms.Pinpointing brainstem mechanisms responsible for autonomic dysfunction in Rett syndrome: therapeutic perspectives for 5-HT1A agonists.Effect of Sarizotan, a 5-HT1a and D2-like receptor agonist, on respiration in three mouse models of Rett syndromeLevodopa, motor fluctuations and dyskinesia in Parkinson's disease.The effects of BMY-14802 against L-DOPA- and dopamine agonist-induced dyskinesia in the hemiparkinsonian ratSerotonin System Implication in l-DOPA-Induced Dyskinesia: From Animal Models to Clinical Investigations.Antidepressant-like properties of sarizotan in experimental Parkinsonism.Parkinson's disease: genetics and beyond.Effects of sarizotan in animal models of ADHD: challenging pharmacokinetic-pharmacodynamic relationships.Intramolecular carbolithiation of N-allyl-ynamides: an efficient entry to 1,4-dihydropyridines and pyridines - application to a formal synthesis of sarizotan.Serotonergic targets for the treatment of L-DOPA-induced dyskinesia.Study of the antidyskinetic effect of eltoprazine in animal models of levodopa-induced dyskinesia.
P2860
Q24564963-76B52232-9A42-49C9-9A1C-42B7E7B7BDCBQ30494674-754DD0A8-D072-4F3A-8C91-DDE021382170Q33687521-8DF649E9-DB22-42F8-924D-9ED400055A3CQ33799538-86F3FD03-4CBC-4E1A-8C90-80C4942F6B62Q36573882-5D7ECE2B-4CD4-46E0-A5EA-74A2A086718AQ36852272-B3395DF0-AE54-4BB1-BA69-C6F549530B5BQ38218100-3AFDC9BD-2A5D-4811-BD6B-85BBA11A2C3AQ39328856-19A502E6-556A-4421-92EF-542735FC1ABBQ39416222-2A981E94-C5D5-487E-823F-7568FFF8C8ACQ41184173-64D433FD-71F6-4ADE-AA3D-FF6DB6D9EB5BQ43058056-A09524F6-24FE-4D49-8632-0493F6530718Q48300577-03C22BED-10A9-432F-90BD-F6E688249A82Q51832640-19C51B39-E343-4BE4-AACA-378818507600
P2860
Sarizotan, a serotonin 5-HT1A receptor agonist and dopamine receptor ligand. 1. Neurochemical profile.
description
2003 nî lūn-bûn
@nan
2003 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Sarizotan, a serotonin 5-HT1A ...... and. 1. Neurochemical profile.
@ast
Sarizotan, a serotonin 5-HT1A ...... and. 1. Neurochemical profile.
@en
Sarizotan, a serotonin 5-HT1A ...... and. 1. Neurochemical profile.
@nl
type
label
Sarizotan, a serotonin 5-HT1A ...... and. 1. Neurochemical profile.
@ast
Sarizotan, a serotonin 5-HT1A ...... and. 1. Neurochemical profile.
@en
Sarizotan, a serotonin 5-HT1A ...... and. 1. Neurochemical profile.
@nl
prefLabel
Sarizotan, a serotonin 5-HT1A ...... and. 1. Neurochemical profile.
@ast
Sarizotan, a serotonin 5-HT1A ...... and. 1. Neurochemical profile.
@en
Sarizotan, a serotonin 5-HT1A ...... and. 1. Neurochemical profile.
@nl
P2093
P1476
Sarizotan, a serotonin 5-HT1A ...... and. 1. Neurochemical profile.
@en
P2093
C A Seyfried
C Van Amsterdam
G D Bartoszyk
H E Greiner
W Rautenberg
P2888
P304
P356
10.1007/S00702-003-0094-7
P577
2003-12-31T00:00:00Z